Good Research Practices for Measuring Drug Costs in Cost-Effectiveness Analyses: A Societal Perspective: The ISPOR Drug Cost Task Force Report-Part II.

Autor:	Garrison LP Jr (AUTHOR), Mansley EC (AUTHOR), Abbott TA 3rd (AUTHOR), Bresnahan BW (AUTHOR), Hay JW (AUTHOR), Smeeding J (AUTHOR)
Zdroj:	Value in Health. Jan/Feb2010, Vol. 13 Issue 1, p8-13. 6p.
Databáze:	Academic Search Ultimate
Externí odkaz:	Zobrazit plný text záznamu Full Text from ScienceDirect Plný text